Chamomile for Anxiety
The first trial of chamomile for anxiety enrolled 61 people, ran for eight weeks, and barely reached statistical significance. That is not the opening a supplement seller would choose, but it is the honest one — and it is also why I like this herb more than most of the ones on this site. Chamomile has a small, real evidence base built by one research group over seven years, with the same extract tested in three linked studies. The effect is modest, the trials are small, and the tea in your kitchen is not the same thing that was tested. If you can live with those three facts, the rest of this page is useful.
No affiliate links on this page — just the papers.
The One Trial Everyone Quotes
The study behind nearly every chamomile claim was published in 2009 by Amsterdam and colleagues at the University of Pennsylvania. Sixty-one outpatients with mild to moderate generalised anxiety disorder were enrolled, and 57 were randomised to either a pharmaceutical-grade chamomile extract or a placebo for eight weeks. The capsules held 220 mg of extract standardised to 1.2% apigenin, the flavonoid usually credited with chamomile’s calming action.
The result: anxiety scores on the Hamilton scale fell further with chamomile than with placebo, with a p-value of 0.047 — just inside the usual threshold for statistical significance. Every secondary measure moved in the same direction, which counts for something, but the study was not powered to prove those smaller differences. Adverse events were no more common with chamomile than with placebo, and one person in each group stopped treatment because of side effects.
Read that again and notice what it does not say. It does not say chamomile works as well as a prescription drug. It does not say it works for severe anxiety — the participants had mild to moderate symptoms. And a p-value of 0.047 from 57 people is the kind of result that can vanish in a bigger trial. The authors said so themselves: the results suggest chamomile “may have modest anxiolytic activity” and need replication.
What the Longer Trial Found
The same group came back in 2016 with a bigger, longer study, and this is the one I find most convincing — partly because of what it failed to prove. They enrolled 179 people with moderate to severe generalised anxiety disorder. Everyone got open-label chamomile extract at 1,500 mg a day for up to eight weeks first. Of those, 58.1% met the researchers’ criteria for response, anxiety scores on the GAD-7 scale fell by an average of 8.4 points, and adverse events showed up in 11.7% of people, with no serious adverse events at all.
Then came the hard part. The 93 people who had responded were randomised to keep taking chamomile or switch to placebo for 26 weeks, to see whether it prevented relapse. Relapse happened in 15.2% of the chamomile group and 25.5% of the placebo group — a difference in the right direction, but not statistically significant (hazard ratio 0.52, p = 0.16). The authors were blunt about why: the sample was small and fewer placebo patients relapsed than expected, so the trial lacked the power to settle the question.
But there was a second finding in the same paper that did reach significance. During those 26 weeks, people who stayed on chamomile kept significantly lower anxiety symptoms than people on placebo (p = 0.0032). So the honest summary of the long trial is split: chamomile kept symptoms lower, but it did not prove it prevents relapse. Both halves matter, and most write-ups only quote one of them.
A Side Note on Low Mood
The 2009 trial’s data got a second look in 2012, when the same team checked whether chamomile also lifted depression scores in the anxious participants. It did: depression scores on the Hamilton scale fell significantly more with chamomile than with placebo across all participants (p < .05). This was an exploratory re-analysis, not a trial designed to test depression, so treat it as a hint rather than a finding. Still, it fits a pattern I keep seeing in this literature — anxiety and low mood travel together, and the things that help one often nudge the other.
Tea vs Extract: Why the Form Matters
Here is the part that trips people up. Every trial above used a pharmaceutical-grade extract in capsules, standardised to a measured apigenin content. A cup of chamomile tea is not that. Tea contains apigenin too, but in much smaller and more variable amounts, and no trial has tested whether a nightly cup of tea reduces anxiety scores.
That does not mean the tea is useless. A warm, caffeine-free drink before bed is a decent wind-down ritual, and rituals matter — our guide to reducing anxiety naturally starts with sleep for a reason. It does mean you should not expect the tea to reproduce the trial results. If you want what was actually tested, you are looking for a standardised extract, and you should check the label the way I check every label on this site: the extract, the standardisation, and the dose should all be printed. The trials used 220 mg of extract standardised to 1.2% apigenin in the first study, and 1,500 mg a day of extract in the later studies. Those are the doses the evidence covers — nothing else.
The US National Center for Complementary and Integrative Health puts it plainly: there is not enough reliable evidence to rate chamomile’s clinical usefulness for any specific condition, though preliminary studies suggest a supplement might help generalised anxiety disorder. That is a fair summary, and it matches what the trials show.
Safety: Allergies and Drug Interactions
Chamomile’s safety record in the trials was good — mild side effects, no serious events, and adverse-event rates similar to placebo. The real-world picture has two warnings worth knowing.
First, allergies. Chamomile is in the daisy family, and the NCCIH says people allergic to related plants such as ragweed, chrysanthemums, marigolds or daisies are more likely to react. Reactions are uncommon but can be severe, including anaphylaxis. If ragweed sets off your hay fever, be careful with chamomile, and skip it if you have ever reacted to a daisy-family plant.
Second, medicines. Interactions between chamomile and warfarin (a blood thinner) and some drugs processed by the liver have been reported, and the NCCIH notes there are theoretical reasons to suspect it might interact with sedatives too. Little is known about chamomile in pregnancy or while breastfeeding. None of this makes chamomile dangerous for most people — the NCCIH calls it likely safe in the amounts found in teas, and possibly safe for short-term medicinal use in adults. It does mean you should tell your doctor or pharmacist if you take regular medication, especially a blood thinner.
What Chamomile Won’t Do
It won’t treat an anxiety disorder on its own. It won’t work overnight — the trials ran eight weeks before measuring the effect. It won’t fix anxiety that is really being driven by bad sleep or too much caffeine, and it is not a substitute for therapy or prescribed medication. The NCCIH also notes there is very little information on chamomile for insomnia, and the one study on insomnia found no benefit — so if you are buying it mainly for sleep, the evidence is thinner than the marketing suggests. Compare it against the other options in our best supplements for anxiety roundup before spending anything.
The Honest Bottom Line
Chamomile has one of the cleaner small evidence bases in the herbal world: a placebo-controlled trial with a modest but real effect, a longer trial showing symptoms stayed lower on the extract, and a safety record with no serious events in the trials. The effect is small, the samples are small, the relapse question is unanswered, and the tea is not the extract. If you are a healthy adult with mild to moderate anxiety, you use a standardised extract, and you have cleared it with your doctor, the evidence says you might feel a bit calmer after eight weeks. That “might” and that “bit” are the honest version of the claim.
Frequently Asked Questions
Does chamomile tea help with anxiety?
No trial has tested chamomile tea itself for anxiety. The trials used standardised extract capsules. A cup of tea is a pleasant caffeine-free ritual, but it is not the thing the evidence covers.
How long does chamomile take to work?
The trials ran eight weeks before measuring the effect, and the longer study used twelve weeks of open-label treatment before the maintenance phase. Nothing in the trial record supports judging it after a few days.
What dose was used in the trials?
The 2009 trial used 220 mg of extract standardised to 1.2% apigenin. The 2016 studies used 1,500 mg a day of pharmaceutical-grade extract. These are the doses the evidence covers — they are not recommendations.
Can I take chamomile with an SSRI?
There is no good trial data on combining chamomile with antidepressants. Ask the doctor who prescribed the SSRI, and read our guide to anxiety supplements and SSRI interactions for the combinations where the evidence is clearer.
Is chamomile safe if I have hay fever?
Be careful. Chamomile is related to ragweed, chrysanthemums, marigolds and daisies, and allergic reactions — rarely severe ones — are more likely if you react to those plants. If in doubt, skip it or ask an allergist.
Does chamomile help with sleep?
The NCCIH says there is very little information on chamomile for insomnia, and the one study found no benefit. Sleep is covered properly in our sleep and anxiety guide.
Sources
- Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29(4):378–382. PMID: 19593179 · DOI: 10.1097/JCP.0b013e3181ac935c — 57 randomised, 220 mg extract standardised to 1.2% apigenin, 8 weeks; HAM-A fell more with chamomile (P=0.047); adverse events similar to placebo.
- Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine. 2016;23(14):1699–1705. PMID: 27912871 · DOI: 10.1016/j.phymed.2016.10.013 — 179 people, 1,500 mg/day open-label up to 8 weeks; 58.1% responded; GAD-7 fell 8.4 points; adverse events 11.7%, none serious.
- Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial. Phytomedicine. 2016;23(14):1735–1742. PMID: 27912875 · DOI: 10.1016/j.phymed.2016.10.012 — 93 responders randomised to 26 weeks chamomile or placebo; relapse 15.2% vs 25.5%, not significant (P=0.16); symptoms stayed lower on chamomile (P=0.0032).
- Amsterdam JD, Shults J, Soeller I, Mao JJ, Rockwell K, Newberg AB. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Altern Ther Health Med. 2012;18(5):44–49. PMID: 22894890 — exploratory re-analysis of the 2009 trial; depression scores fell more with chamomile (P<.05).
- National Center for Complementary and Integrative Health. Chamomile: Usefulness and Safety. nccih.nih.gov/health/chamomile — likely safe in tea amounts; allergic reactions more likely with ragweed/daisy-family allergy; warfarin and liver-metabolised drug interactions reported; little known in pregnancy.
This guide is general information, not medical advice, and it is not a substitute for your own doctor — especially if you take regular medication or have a health condition. If anxiety is seriously affecting your life, talk to a doctor promptly rather than trying supplements first.
